MERXIN and Gerresheimer worked successful together to realize the shortest possible time to market for the MERXIN MRX003 Capsule DPI
Wackersdorf, June 13, 2022: Gerresheimer has assumed…
Partners join forces to improve lives of millions of Parkinson’s patients worldwide with a transformative technology-based solution Gerresheimer participates in seed-round of the Finnish MedTech…
Duesseldorf, June 08, 2022 – The Annual General Meeting of Gerresheimer AG has approved the payment of a dividend of EUR 1.25 per share for the 2021 financial year. This represents a payout ratio of…
Wackersdorf, May 30, 2022: The drug development company ISR has signed an agreement with Gerresheimer for large-scale production of the IcoOne nasal inhaler, for its phase III study of its dry powder…
Container-level traceability from production to point-of-care (PoC)
Düsseldorf/Olten, May 24, 2022. The Gerresheimer traceability concept ensures complete transparency throughout the value chain and…
Düsseldorf/Kosamba, May 16, 2022. Gerresheimer has significantly ramped up its glass and plastic production capacities in India. A new modern plant to produce high quality plastic containers and…
Duesseldorf/Kosamba, May 16, 2022. Gerresheimer has significantly ramped up its glass and plastic production capacities in India to satisfy its global pharma customer needs. A new modern plant to…
Duesseldorf/Paris, May 11, 2022. Which packaging or delivery solution is best suited to the respective active ingredient? In addition to Gerresheimer's experts, the g guide has recently been…
Partners are developing needle-free drug delivery platform for biologics and biosimilars This Innovative solution improves patient’s quality of life, especially for people with chronic diseases…
